QUEBEC CITY, June 26 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, is actively finalizing the imminent launch of its new Previstage(TM) GCC Colorectal Cancer Staging Test planned for this summer, and appoints Mr. Phillip Wells as Vice President, Marketing and National Sales to drive this launch and commercial growth of the Company.
